The trustee filed a notice for the selection of Successful Bidder in the US Bankruptcy Court for the sale of substantially all the assets of Akorn Holding Company LLC on May 18, 2023. As a result of the auction conducted on May 10, 2023, Hikma Pharmaceuticals USA Inc., Long Grove Pharmaceuticals, LLC, TEVA Pharmaceuticals, Inc., Oak Tree Pharma LLC, Sentiss AG, ANI Pharmaceuticals, Inc., Alcon Pharmaceuticals Ltd, Stira Pharmaceuticals, LLC, Provepharm SAS, Epic Pharma LLC, Saptalis Pharmaceuticals, LLC, PAI Holdings, LLC, Mission Pharmacal Company, Chartwell Rx Sciences LLC, Aurobindo Pharma USA, Inc., Cronus Pharma LLC, Domes Pharma S.A., and Raisin Holdings, Inc. have been selected as the winning bidders for the sale of debtor?s substantially all its assets.